Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | -4.23% | -7.65% | -36.60% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 42.29M | Sales 2025 * | 52.34M | Capitalization | 1.06B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -215M | EV / Sales 2024 * | 22.3 x |
Net cash position 2024 * | 120M | Net cash position 2025 * | 2M | EV / Sales 2025 * | 20.3 x |
P/E ratio 2024 * |
-6.33
x | P/E ratio 2025 * |
-5.88
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.02% |
Latest transcript on AbCellera Biologics Inc.
1 day | -4.23% | ||
1 week | -7.65% | ||
Current month | -7.65% | ||
1 month | -10.40% | ||
3 months | -26.27% | ||
6 months | -25.21% | ||
Current year | -36.60% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +9.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.62 | -4.23% | 1,082,438 |
24-06-06 | 3.78 | +0.80% | 1,203,836 |
24-06-05 | 3.75 | -0.79% | 1,539,429 |
24-06-04 | 3.78 | -2.58% | 1,077,007 |
24-06-03 | 3.88 | -1.02% | 1,249,847 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.60% | 1.06B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ABCL Stock